Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
---|---|---|---|---|---|---|---|
21-Apr-2025 | 922.95 | 926.7 | 906.05 | 915.95 | 21,342 | 20,87,87,605 | 74,907 |
22-Apr-2025 | 920 | 925.5 | 905.25 | 917.25 | 15,441 | 11,17,22,854.25 | 42,861 |
23-Apr-2025 | 922 | 935 | 912.4 | 923.85 | 16,211 | 13,10,46,165.2 | 69,004 |
24-Apr-2025 | 935 | 967.95 | 919.6 | 952.65 | 57,411 | 65,22,50,051.75 | 2,56,267 |
25-Apr-2025 | 958 | 962 | 901 | 910 | 37,997 | 39,82,23,832.75 | 1,15,905 |
28-Apr-2025 | 911.9 | 916.8 | 897.55 | 907.4 | 12,434 | 12,12,29,415.55 | 64,548 |
29-Apr-2025 | 909 | 918.85 | 880 | 894.7 | 13,170 | 10,26,46,453.7 | 51,636 |
30-Apr-2025 | 887.5 | 905.1 | 866.3 | 897.95 | 27,461 | 24,89,42,869.8 | 99,075 |
02-May-2025 | 897.9 | 909.7 | 871.55 | 906.95 | 24,868 | 14,15,09,543.8 | 59,366 |
05-May-2025 | 900 | 917.05 | 893.55 | 908 | 15,995 | 9,68,97,750.8 | 44,371 |
06-May-2025 | 908 | 912.15 | 845.35 | 872.25 | 19,229 | 12,11,77,787.55 | 60,243 |
07-May-2025 | 858.95 | 898.8 | 840 | 881.75 | 14,312 | 8,35,44,431.45 | 34,601 |
08-May-2025 | 881.75 | 906 | 865 | 881.05 | 18,948 | 12,91,81,480.4 | 55,131 |
09-May-2025 | 860 | 875 | 845.15 | 867.85 | 17,051 | 11,00,56,143.9 | 57,781 |
12-May-2025 | 871.5 | 907 | 870 | 879.15 | 15,065 | 12,93,92,651.95 | 66,494 |
13-May-2025 | 879.15 | 915 | 879.15 | 907.05 | 15,383 | 13,21,17,012.75 | 63,645 |
14-May-2025 | 906 | 908.6 | 894.6 | 904.4 | 10,826 | 8,37,50,752.25 | 49,200 |
15-May-2025 | 904.4 | 921.55 | 900.2 | 905.6 | 16,622 | 21,28,18,199.05 | 1,34,305 |
16-May-2025 | 913.75 | 950 | 905.6 | 945.6 | 64,544 | 1,36,53,99,861.15 | 4,82,932 |
19-May-2025 | 956.95 | 974.35 | 939 | 960.1 | 54,735 | 85,45,01,574.15 | 4,11,363 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.